CompletedPhase 4

Study of Lactobacillus in Adjuvant Treatment of RVVC

China140 participantsStarted 2020-07-01

Plain-language summary

We are trying to determine if Clotrimazole vaginal tablets with oral Lactobacillus is better than Clotrimazole vaginal tablets in Preventing the Recurrence of vulvovaginalcandidiasis

Who can participate

Age range18 Years – 52 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Taking / injecting antibiotics in the past two weeks;
✕. A woman who intends to be pregnant, pregnant or lactating;
✕. Long term use of contraceptives and immunosuppressants;
✕. Postmenopausal;
✕. There was no same fixed sexual partner (RSP) before and after treatment
✕. Patients with severe gastrointestinal diseases, including colorectal cancer, IBS, IBD, chronic or acute diarrhea, long-term constipation, etc., or receiving gastrointestinal surgery and abdominal surgery within one year, such as cholecystectomy;
✕. Patients with severe heart, liver and kidney dysfunction, mental diseases, infectious diseases, tumors, severe anemia, and severe autoimmune diseases (such as rheumatoid arthritis, lupus erythematosus, etc.)

What they're measuring

The cure rate of RVVC,

Timeframe: 6 months

Trial details

NCT IDNCT04699240

SponsorPeking University Shenzhen Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-12-30

View on ClinicalTrials.gov More Recurrent Vulvovaginal Candidiasis trials